![](https://pregnancy28.com/wp-content/themes/pregnancy/themes/custom/kedrion_theme/public/images/curva_pink.png)
![](https://pregnancy28.com/wp-content/themes/pregnancy/themes/custom/kedrion_theme/public/images/curva_pink_mobile.png)
![](https://pregnancy28.com/wp-content/themes/pregnancy/themes/custom/kedrion_theme/public/images/curva_blue.png)
![](https://pregnancy28.com/wp-content/themes/pregnancy/themes/custom/kedrion_theme/public/images/curva_blue-mobile.png)
![](https://pregnancy28.com/wp-content/uploads/2021/03/shutterstock_572900056-1.jpg)
Incidence of Rh Immunization
Without intervention, approximately 8% to 17% of mothers in Rh-incompatible pregnancies become immunized at delivery (postpartum) and another 1% to 2% become immunized during pregnancy (antepartum). Termination of pregnancy carries a risk of immunization of 3% to 6%. similar to the 2% to 5% incidence seen after amniocentesis or chorionic villus sampling. 1,3,7,8
As an example in USA, using a conservative estimate of approximately 10% chance of Rh immunization, approximately 45,000 women per year are potentially at risk of immunization each year (446,000 X 10%).
INCIDENCE OF RH IMMUNIZATION IMAGE
![](https://pregnancy28.com/wp-content/uploads/2021/03/incidence-of-rh-immunization-table.png)
1 Rubin E, Farber JL. Developmental and genetic diseases. In:Rubin E, Farber JL, eds. Pathology. 2nd ed. Philadelphia, PA: J.B.Lippincott Company; 1994:255-8.
3 Turgeon ML. Hemolytic disease of the newborn. In: Turgeon ML, ed. Fundamentals of Immunohematology: Theory and Technique.Philadelphia, PA: Lea & Febiger; 1989: 321-43
7 Bowman JM. The prevention of Rh immunization. Transfus Med Rev.1988;2:129-150.
8. Zoon KC. Dear Colleague Letter, Office of Health Affairs of the FDA,Washington, DC: 1996.